omega-n-methylarginine has been researched along with fluconazole in 8 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (fluconazole) | Trials (fluconazole) | Recent Studies (post-2010) (fluconazole) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 9,343 | 721 | 3,664 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | fluconazole (IC50) |
---|---|---|---|
Lanosterol 14-alpha demethylase | Candida albicans SC5314 | 0.1296 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 9.21 | |
Sterol 14-alpha demethylase | Trypanosoma cruzi strain CL Brener | 0.88 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellien, J; Bourkaib, R; Eltchaninoff, H; Iacob, M; Joannides, R; Thuillez, C | 1 |
Bellien, J; Joannides, R; Thuillez, C | 1 |
Bellien, J; Favre, J; Gao, J; Iacob, M; Joannidès, R; Richard, V; Thuillez, C | 1 |
Bellien, J; Dreano, Y; Gutierrez, L; Iacob, M; Joannides, R; Lucas, D; Mercier, A; Monteil, C; Remy-Jouet, I; Thuillez, C; Vendeville, C | 1 |
Bellien, J; Blot, E; Donnadieu, N; Dreano, Y; Gutierrez, L; Iacob, M; Joannides, R; Lucas, D; Mercier, A; Remy-Jouet, I; Thuillez, C | 1 |
Herr, MD; Leuenberger, UA; Sinoway, LI; Spilk, S | 1 |
De Staercke, C; Hayek, S; Hooper, WC; Kavtaradze, N; Lin, J; Manatunga, A; Murrow, JR; Ozkor, MA; Quyyumi, AA; Rahman, AM | 1 |
Bellien, J; Djerada, Z; Duflot, T; Iacob, M; Joannides, R; Remy-Jouet, I; Roca, F; Wils, J | 1 |
5 trial(s) available for omega-n-methylarginine and fluconazole
Article | Year |
---|---|
AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Aspirin; Benzimidazoles; Benzoates; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Fluconazole; Humans; Male; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Radial Artery; Regional Blood Flow; Telmisartan; Vascular Resistance; Vasodilation; Vasodilator Agents | 2007 |
Role of endothelium-derived hyperpolarizing factor in the regulation of radial artery basal diameter and endothelium-dependent dilatation in vivo.
Topics: Biological Factors; Endothelium; Fluconazole; Hot Temperature; Humans; Male; omega-N-Methylarginine; Radial Artery; Tetraethylammonium; Vasodilation | 2008 |
Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans.
Topics: Adult; Animals; Benzimidazoles; Biological Factors; Blood Pressure; Elasticity; Endothelium, Vascular; Enzyme Inhibitors; Fluconazole; Hot Temperature; Humans; Hypertension; Indoles; Male; Mice; Mice, Inbred Strains; Nitric Oxide; omega-N-Methylarginine; Oximes; Potassium Channel Blockers; Radial Artery; Regional Blood Flow; Tetraethylammonium; Vasodilation; Young Adult | 2010 |
Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.
Topics: 14-alpha Demethylase Inhibitors; Adult; Eicosanoids; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Female; Fluconazole; Hot Temperature; Humans; Hyperemia; Hypertension; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Pulsatile Flow; Radial Artery; Reactive Oxygen Species; Skin; Stress, Mechanical | 2012 |
Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans.
Topics: Adult; Biological Factors; Bradykinin; Cytochrome P-450 Enzyme System; Female; Fluconazole; Forearm; Humans; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Potassium Channels, Calcium-Activated; Regional Blood Flow; Tetraethylammonium; Tissue Plasminogen Activator; Vasodilation | 2014 |
3 other study(ies) available for omega-n-methylarginine and fluconazole
Article | Year |
---|---|
Impaired role of epoxyeicosatrienoic acids in the regulation of basal conduit artery diameter during essential hypertension.
Topics: Adult; Blood Pressure; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Eicosanoids; Endothelium, Vascular; Essential Hypertension; Female; Fluconazole; Humans; Hypertension; Male; Middle Aged; omega-N-Methylarginine; Radial Artery; Regional Blood Flow; Vasoconstriction; Vasodilation | 2012 |
Endothelium-derived hyperpolarizing factor contributes to hypoxia-induced skeletal muscle vasodilation in humans.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Biological Factors; Blood Flow Velocity; Blood Pressure; Cytochrome P-450 CYP2C9; Endothelium, Vascular; Enzyme Inhibitors; Female; Fluconazole; Forearm; Heart Rate; Humans; Hypoxia; Infusions, Intra-Arterial; Male; Muscle, Skeletal; Nitric Oxide Synthase; omega-N-Methylarginine; Pulmonary Ventilation; Regional Blood Flow; Vasodilation | 2013 |
Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging.
Topics: Adult; Age Factors; Aged; Aging; Cytochrome P-450 Enzyme Inhibitors; Eicosanoids; Endothelium, Vascular; Female; Fluconazole; Humans; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Peripheral Arterial Disease; Radial Artery; Ultrasonography, Doppler; Vasodilation; Young Adult | 2018 |